Eli Lilly & Co. vs Bio-Techne Corp.
LLY vs TECH — side-by-side comparison from reported financials. LLY leads 10, TECH leads 2 of 12 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
| Metric | LLY | TECH |
|---|---|---|
| Price | $1 177.20 | $72.44 |
| Market cap | $1.05T | $11.4B |
| Revenue (TTM) | $79.7B | $1.22B |
| Revenue growth | +31.7% | +2.3% |
| Net margin | 33.5% | 15.0% |
| Free cash flow | $18.2B | $263M |
| Net cash (debt) | ($35.2B) | ($23.6M) |
| 1-year price return | +37.6% | +20.9% |
| P/E | 41.6 | 62.5 |
| P/E vs own history (cheap-side %) | 88% | 14% |
| Dividend yield | 0.52% | 0.44% |
| Return on equity | 93% | 9% |
| Altman Z-score | 7.10 | 15.94 |
| CV checks passed | 11 of 11 | 8 of 11 |
| Employees | 50,000 | 3,000 |
Full résumé-style profiles: LLY CV · TECH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.